Multiple mutations of the p53 gene in human mammary carcinoma

Mutation Research - DNA Repair

Volumn 435, Issue 3, 1999, Pages 263-269

  Meng, Lou ^a   Lin, Lin ^a   Zhang, Hua ^a   Nassiri, Mehdi ^a   Morales, Azorides R ^a   Nadji, Mehrdad ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Multiple mutations; p53

Indexed keywords

PROTEIN P53; TAQ POLYMERASE;

ARTICLE; BREAST CARCINOMA; EXON; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CARCINOMA; CLONING, MOLECULAR; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, P53; HUMANS; MUTATION; POLYMERASE CHAIN REACTION;

EID: 0032778582     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(99)00053-1     Document Type: Article

References (29)

1. Hollstein M., Rice K., Greenblatt M.S., Soussi T., Fuchs R., Sorlie T., Hovig E., Smith-Sorensen B., Montesano R., Harris C.C. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22:1994;3551-3555.
2. Spruck C.H. III, Rideout W.M. III, Olumi A.F., Ohneseit P.F., Yang A.S., Tasi Y.C., Nichols P.W., Horn T., Hermann G.G., Steven R.K., Yu M.C., Jones P.A. Distinct pattern of p53 mutations in bladder cancer relationship to tobacco usage. Cancer Res. 53:1993;1162-1166.
3. Zigler A., Leffell D.J., Kunala S., Sharma H.W., Gailani M., Simon J.A., Halperin A.J., Baden H.P., Shapiro P.E., Bale A.E., Bash D.E. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4216-4220.
4. Taylor J.A., Li Y., He M., Mason T., Mettin C., Vogler W.J., Maygarden S., Liu E. p53 Mutations in bladder tumors from arylamine-exposed workers. Cancer Res. 56:1996;294-298.
5. Nadji M., Meng L., Lin L., Nassiri M., Morales A.R. Detection of p53 gene abnormality by sequence analysis of archival paraffin tissue. Diagn. Mol. Pathol. 5:1996;279-283.
6. Levine A.J., Perry M.E., Chang A., Silver A., Dittmer D., Wu M., Welsh D. The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br. J. Cancer. 69:1994;409-416.
7. Harris C., Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 329:1993;1318-1327.
8. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878.
9. Ozbun M.A., Butel J.S. Tumor suppressor p53 mutations and breast cancer: a critical analysis. Adv. Cancer Res. 66:1995;71-141.
10. Soussi T., Legros Y., Lubin R., Ory K., Schlichtolz B. Multifactorial analysis of p53 alteration in human cancer: a review. Int. J. Cancer. 57:1994;1-9.
11. Elledge R.M. Assessing p53 Status in breast cancer prognosis: where should you put the thermometer if you think your p53 is sick? J. Natl. Cancer Inst. 88:1996;141-143.
12. Hall P.A., Lane D.P. p53 in tumor pathology: can we trust immunohistochemistry? - Revisited. J. Pathol. 172:1994;1-4. (Editorial).
13. Sjogren S., Inganas M., Norberg T., Lindgren A., Nordgren H., Holmberg L., Bergh J. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J. Natl. Cancer Inst. 88:1996;173-182.
14. Hollstein M., Shomer B., Greenblatt M., Soussi T., Hovig E., Montesano R., Harris C.C. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res. 24:1996;141-146.
15. Kanjilal S., Strom S.S., Clayman G.L., Weber R.S., el-Naggar A.K., Kapur V., Cummings K.K., Hill L.A., Spitz M.R., Kripke M.L. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence of field cancerization. Cancer Res. 55:1995;3604-3609.
16. Carbore D., Chiba I., Mitsudomi T. Polymorphism at codon 213 within p53 gene. Oncogene. 6:1991;1691-1692.
17. Strauss B.S. Silent and multiple mutations in p53 and the question of the hypermutability of tumors. Carcinogenesis. 18:1997;1445-1452.
18. Rodin S.N., Holmquist G.R., Rodin A.S. CpG transition strand asymmetry and hitch-hiking mutations as measures of turmorigenic selection in shaping the p53 mutation spectrum. Int. J. Mol. Med. 1:1998;191-199.
19. Seidman M.M., Bredberg A., Seethararam S., Kraemer K. Multiple point mutations in a shuttle vector propagated in human cells: evidence for an error-prone DNA polymerase activity. Proc. Natl. Acad. Sci. U.S.A. 84:1987;4944-4948.
20. Harwood J., Tachibana A., Mueth M. Multiple dispersed spontaneous mutations: a novel pathway of mutation in a malignant cell line. Mol. Cell. Biol. 11:1991;3163-3170.
21. Greenblatt M.S., Grollman A.P., Harris C.C. Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model. Cancer Res. 56:1996;2130-2136.
22. Sommer S.S., Cuningham J., McGovern R.M., Saitoh S., Schroeder J.J., Wold L.E., Kovach J.S. Pattern of p53 gene mutations in breast cancer of women of the midwestern United States. J. Natl. Cancer Inst. 84:1992;246-252.
23. Blaszyk H., Hartmann A., Tamura Y., Saitoh S., Cunningham J.M., McGovern R.M., Schroeder J.J., Schaid D.J., Ii K., Monden Y., Morimoto T., Komaki K., Sasa M., Hirata K., Okazaki M., Kovach J.S., Sommer S.S. Molecular epidemiology of breast cancers in northern and southern Japan: the frequency, clustering and patterns of p53 gene mutations differ among these two low-risk populations. Oncogene. 13:1996;2159-2166.
24. Shiao Y.H., Chen V.W., Scheer W.D., Wu X.C., Correa P. Racial disparity in the association of p53 gene alterations in breast cancer survival. Cancer Res. 55:1995;1485-1490.
25. Saitoh S., Cunningham J.M., De Vries E.M., McGovern R.M., Schroeder J.J., Hartmann A., Blaszyk H., Wold L.E., Schaid D., Sommers S.S., Kovach J.S. p53 gene mutations in breast cancers in midwestern US women; null as well as missense-type mutations are associated with poor prognosis. Oncogene. 9:1994;2869-2875.
26. Meng L., Lin L., Fresno M., Morales A.R., Nadji M. Frequency and pattern of p53 mutation in a cohort of Spanish women with node-negative breast cancer. Intl. J. Oncol. 15:1999;555-558.
27. Chernova O.B., Chernov M.V., Argawal M.L., Taylor W.R., Stark G.R. The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. TIBS. 20:1995;341-343.
28. Eyfjord J.E., Thorlacius S., Steinarsdottir M., Valgardsdottir R., Ogmundsdottir H.M., Anamthawat-Jonsson K. p53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Res. 55:1995;646-651.
29. Leob L.A., Christians F.C. Multiple mutations in human cancers. Mutat. Res. 350:1996;279-286.